Cas:217314-46-0 2-fluoro-6-methoxy-4-methylaniline manufacturer & supplier

Chemical Name:2-fluoro-6-methoxy-4-methylaniline

CAS.NO:217314-46-0

Synonyms:Benzenamine,2-fluoro-6-methoxy-4-methyl;2-Fuloro-4-methy-6-methoxyaniline;Benzenamine,2-fluoro-6-methoxy-4-methyl-(9CI)

Molecular Formula:C₈H₁₀FNO

Molecular Weight:155.17000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:214.661ºC at 760 mmHg

Density:1.139 g/cm3

Index of Refraction:

PSA:35.25000

Exact Mass:155.07500

LogP:2.30610

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzenamine,2-fluoro-6-methoxy-4-methyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenamine,2-fluoro-6-methoxy-4-methyl-(9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fuloro-4-methy-6-methoxyaniline Use and application,Benzenamine,2-fluoro-6-methoxy-4-methyl-(9CI) technical grade,usp/ep/jp grade.

Related News: DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 2-fluoro-6-methoxy-4-methylaniline manufacturer The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 2-fluoro-6-methoxy-4-methylaniline supplier With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near 2-fluoro-6-methoxy-4-methylaniline vendor DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 2-fluoro-6-methoxy-4-methylaniline factory According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.